Literature DB >> 22282329

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.

Jason H Y Wu1, Rozenn N Lemaitre, Irena B King, Xiaoling Song, Frank M Sacks, Eric B Rimm, Susan R Heckbert, David S Siscovick, Dariush Mozaffarian.   

Abstract

BACKGROUND: Experimental studies suggest that long-chain n-3 polyunsaturated fatty acids (n-3 PUFAs) may reduce the risk of atrial fibrillation (AF). Prior studies evaluating fish or n-3 PUFA consumption from dietary questionnaires and incident AF have been conflicting. Circulating levels of n-3 PUFAs provide an objective measurement of exposure. METHODS AND
RESULTS: Among 3326 US men and women ≥65 years of age and free of AF or heart failure at baseline, plasma phospholipid levels of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid were measured at baseline by use of standardized methods. Incident AF (789 cases) was identified prospectively from hospital discharge records and study visit ECGs during 31 169 person-years of follow-up (1992-2006). In multivariable Cox models adjusted for other risk factors, the relative risk in the top versus lowest quartile of total n-3 PUFAs (eicosapentaenoic acid+docosapentaenoic acid+docosahexaenoic acid) levels was 0.71 (95% confidence interval, 0.57-0.89; P for trend=0.004) and of DHA levels was 0.77 (95% confidence interval, 0.62-0.96; P for trend=0.01). Eicosapentaenoic acid and docosapentaenoic acid levels were not significantly associated with incident AF. Evaluated nonparametrically, both total n-3 PUFAs and docosahexaenoic acid showed graded and linear inverse associations with incidence of AF. Adjustment for intervening events such as heart failure or myocardial infarction during follow-up did not appreciably alter results.
CONCLUSIONS: In older adults, higher circulating total long-chain n-3 PUFA and docosahexaenoic acid levels were associated with lower risk of incident AF. These results highlight the need to evaluate whether increased dietary intake of these fatty acids could be effective for the primary prevention of AF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282329      PMCID: PMC3302663          DOI: 10.1161/CIRCULATIONAHA.111.062653

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  60 in total

1.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials.

Authors:  Johanna M Geleijnse; Erik J Giltay; Diederick E Grobbee; Adrianus R T Donders; Frans J Kok
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

2.  Association between physical activity and markers of inflammation in a healthy elderly population.

Authors:  D F Geffken; M Cushman; G L Burke; J F Polak; P A Sakkinen; R P Tracy
Journal:  Am J Epidemiol       Date:  2001-02-01       Impact factor: 4.897

Review 3.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

Review 4.  Epidemiology and natural history of atrial fibrillation: clinical implications.

Authors:  S S Chugh; J L Blackshear; W K Shen; S C Hammill; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

5.  n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.

Authors:  Savina Nodari; Marco Triggiani; Umberto Campia; Alessandra Manerba; Giuseppe Milesi; Bruno M Cesana; Mihai Gheorghiade; Livio Dei Cas
Journal:  Circulation       Date:  2011-08-15       Impact factor: 29.690

6.  Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

Authors:  Salvatore Pepe; Peter L McLennan
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

7.  Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model.

Authors:  Kazuhisa Kitamura; Rei Shibata; Yukiomi Tsuji; Masayuki Shimano; Yasuya Inden; Toyoaki Murohara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 8.  Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials.

Authors:  Tong Liu; Panagiotis Korantzopoulos; Michael Shehata; Guangping Li; Xunzhang Wang; Sanjay Kaul
Journal:  Heart       Date:  2011-04-08       Impact factor: 5.994

Review 9.  Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models.

Authors:  P L McLennan
Journal:  Lipids       Date:  2001       Impact factor: 1.880

10.  The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.

Authors:  Paul Nestel; Hideki Shige; Sylvia Pomeroy; Marja Cehun; Mavis Abbey; Daniel Raederstorff
Journal:  Am J Clin Nutr       Date:  2002-08       Impact factor: 7.045

View more
  64 in total

1.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Authors:  William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

2.  ω-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle.

Authors:  Jason H Y Wu; Dariush Mozaffarian
Journal:  Heart       Date:  2014-01-23       Impact factor: 5.994

Review 3.  Impact of functional foods on prevention of cardiovascular disease and diabetes.

Authors:  Geeta Sikand; Penny Kris-Etherton; Nancy Mariam Boulos
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

Review 4.  N-3 Polyunsaturated Fatty Acids and Atrial Fibrillation: Friend or Foe?

Authors:  Gary Tse; Leonardo Roever; Tong Liu
Journal:  Curr Atheroscler Rep       Date:  2019-04-02       Impact factor: 5.113

Review 5.  The Impact of Diet and Lifestyle on Atrial Fibrillation.

Authors:  Chrishan J Nalliah; Prashanthan Sanders; Jonathan M Kalman
Journal:  Curr Cardiol Rep       Date:  2018-10-12       Impact factor: 2.931

6.  Omega-3 dietary Fatty Acid status of healthy older adults in Tasmania, Australia: an observational study.

Authors:  J K Pittaway; L T Chuang; K D K Ahuja; J M Beckett; R H Glew; M J Ball
Journal:  J Nutr Health Aging       Date:  2015-05       Impact factor: 4.075

Review 7.  Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.

Authors:  David S Siscovick; Thomas A Barringer; Amanda M Fretts; Jason H Y Wu; Alice H Lichtenstein; Rebecca B Costello; Penny M Kris-Etherton; Terry A Jacobson; Mary B Engler; Heather M Alger; Lawrence J Appel; Dariush Mozaffarian
Journal:  Circulation       Date:  2017-03-13       Impact factor: 29.690

8.  Omega 3 and atrial fibrillation: Where are we?

Authors:  Annamaria Martino; Laura Pezzi; Roberta Magnano; Elisa Salustri; Maria Penco; Leonardo Calo'
Journal:  World J Cardiol       Date:  2016-02-26

9.  Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Authors:  Arzu Ulu; Todd R Harris; Christophe Morisseau; Christina Miyabe; Hiromi Inoue; Gertrud Schuster; Hua Dong; Ana-Maria Iosif; Jun-Yan Liu; Robert H Weiss; Nipavan Chiamvimonvat; John D Imig; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

Review 10.  Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis.

Authors:  Chuchun L Chang; Richard J Deckelbaum
Journal:  Curr Opin Lipidol       Date:  2013-08       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.